[Effects of cepharanthin on leukopenia and thrombocytopenia induced by chemotherapy in lung cancer patients].

@article{Suzuki1992EffectsOC,
  title={[Effects of cepharanthin on leukopenia and thrombocytopenia induced by chemotherapy in lung cancer patients].},
  author={Ryujiro Suzuki and Masamichi Hara and Joh Shindoh and Shigemi Matsumoto and Yoshinori Noda and Hideo Gonda and Hiromu Tanaka and Fumio Taki and Kenzo Takagi},
  journal={Gan to kagaku ryoho. Cancer & chemotherapy},
  year={1992},
  volume={19 5},
  pages={647-52}
}
We studied the effects of Cepharanthin (CEP) on bone marrow suppression induced by chemotherapy in 18 primary lung cancer patients (14 NSCLC, 4 SCLC). NSCLC patients received IP (IFM+CDDP) therapy and SCLC patients received ION (IFM+VCR+ACNU) therapy. For the control, we chose the first course and we administered CEP (1 mg/kg) during the second course. The rate of leukopenia and neutropenia was significantly lower during the CEP course than during the control (p less than 0.01). The recovery… CONTINUE READING

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…